A clinical trial conducted within the BC Cervical Cancer Screening Program. HPV FOCAL evaluated the effectiveness and safety of HPV testing compared to the Pap test for cervical cancer prevention.
Principal Investigators: Dr. Gina Ogilvie, Dr. Andrew Coldman
QUEST (Quadrivalent HPV Vaccine Evaluation Study) is a Canada-wide study designed to evaluate whether 2 doses of the HPV vaccine are just as effective as 3 doses at preventing Human Papillomavirus (HPV) infection and cervical cancer.
Principal Investigators: Drs. Gina Ogilvie, Simon Dobson
This study aims to better understand how the HPV vaccine works in HIV positive girls and women over the long term and to clarify how care can be provided to best protect this population from HPV infection and associated cervical cancer and genital warts.
Principal Investigator: Dr. Deborah Money
CARMA-1-PREG is investigating factors related to pre-term deliveries among HIV positive women.
Principal Investigator: Dr. Deborah Money
The purpose of CARMA 7 is to investigate how fetal exposure to the anti-HIV medication Tenofovir may affect the bone and kidney health of infants who are born to HIV+ women.
Principle Investigator: Dr. Ariane Alimenti
Personalized Contraception for Canadians- Decision analytic modelling to support women-centered choices Principal Investigator: Dr. Flora Teng Primary Contact: Weihong Chen, Research Coordinator, 604-875-2424 x 4894, Weihong.chen@ubc.ca